FibroBiologics
FBLG

FibroBiologics (FBLG) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
HC Wainwright & Co.MaintainedBuy$6.00 from $8.00Aug 4, 2026
Maxim GroupDowngradedBuy → HoldMay 4, 2026
HC Wainwright & Co.MaintainedBuy$8.00 from $4.00Apr 16, 2026
D. Boral CapitalDowngradedBuy → HoldMar 26, 2026
D. Boral CapitalMaintainedBuy$7.00Mar 12, 2026
HC Wainwright & Co.MaintainedBuy$4.00 from $5.00Feb 26, 2026
D. Boral CapitalMaintainedBuy$7.00 from $15.00Feb 25, 2026
D. Boral CapitalMaintainedBuy$15.00Jan 6, 2026
HC Wainwright & Co.MaintainedBuy$5.00Jan 2, 2026
D. Boral CapitalMaintainedBuy$15.00Nov 20, 2025
HC Wainwright & Co.MaintainedBuy$5.00 from $10.00Nov 5, 2025
D. Boral CapitalMaintainedBuy$15.00Nov 3, 2025
HC Wainwright & Co.MaintainedBuy$10.00Sep 12, 2025
D. Boral CapitalMaintainedBuy$16.00Sep 10, 2025
HC Wainwright & Co.MaintainedBuy$12.00 from $10.00Aug 5, 2025
D. Boral CapitalMaintainedBuy$16.00Aug 4, 2025
D. Boral CapitalMaintainedBuy$16.00Jul 29, 2025
D. Boral CapitalMaintainedBuy$16.00Jul 9, 2025
D. Boral CapitalMaintainedBuy$16.00Jun 17, 2025
D. Boral CapitalMaintainedBuy$16.00May 15, 2025

Frequently asked questions

  • What is the latest analyst rating on FBLG?

    On Aug 4, 2026, HC Wainwright & Co. maintained FibroBiologics at Buy with a price target of $6.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.